The Clorox Company (NYSE:CLX – Get Free Report) has received an average rating of “Reduce” from the sixteen brokerages that are presently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a sell recommendation and twelve have assigned a hold recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $93.57.
CLX has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $95.00 price target on shares of Clorox in a report on Monday. Citigroup reduced their price objective on shares of Clorox from $97.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, October 14th. Morgan Stanley decreased their target price on shares of Clorox from $97.00 to $87.00 and set an “equal weight” rating for the company in a research report on Thursday, October 15th. Barclays lowered their target price on shares of Clorox from $84.00 to $80.00 and set an “underweight” rating for the company in a research note on Friday. Finally, Evercore set a $99.00 target price on shares of Clorox in a research note on Tuesday, August 4th.
Check Out Our Latest Report on Clorox
Clorox Price Performance
Shares of CLX stock opened at $87.50 on Wednesday. The stock’s 50-day moving average is $91.41 and its 200 day moving average is $94.99. Clorox has a 1-year low of $79.12 and a 1-year high of $128.90. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38. The company has a market cap of $10.58 billion, a P/E ratio of 18.15, a PEG ratio of 2.71 and a beta of 0.59.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.02. The business had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The firm’s revenue was down 2.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Research analysts predict that Clorox will post 5.74 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Wednesday, October 28th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 5.7%. Clorox’s dividend payout ratio is presently 103.73%.
Institutional Trading of Clorox
Several hedge funds and other institutional investors have recently made changes to their positions in CLX. Carnegie Investment Counsel raised its holdings in Clorox by 242.6% in the 3rd quarter. Carnegie Investment Counsel now owns 11,821 shares of the company’s stock worth $958,000 after purchasing an additional 8,371 shares during the period. Nisa Investment Advisors LLC grew its holdings in Clorox by 167.0% in the third quarter. Nisa Investment Advisors LLC now owns 72,129 shares of the company’s stock valued at $5,843,000 after purchasing an additional 45,118 shares during the period. Revisor Wealth Management LLC grew its holdings in Clorox by 128.9% in the third quarter. Revisor Wealth Management LLC now owns 5,999 shares of the company’s stock valued at $486,000 after purchasing an additional 3,378 shares during the period. MBM Wealth Consultants LLC grew its holdings in Clorox by 22.2% in the third quarter. MBM Wealth Consultants LLC now owns 6,634 shares of the company’s stock valued at $537,000 after purchasing an additional 1,203 shares during the period. Finally, Peoples Financial Services CORP. increased its position in shares of Clorox by 193.9% in the third quarter. Peoples Financial Services CORP. now owns 1,061 shares of the company’s stock valued at $86,000 after buying an additional 700 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.
About Clorox
The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.
Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.
Recommended Stories
- Five stocks we like better than Clorox
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
